Dr. Hugo E.M. Vereecke (°04/07/1972) became a medical doctor at the Ghent University, Belgium (1997) and consultant anesthesiologist (2002) at the University Hospital Ghent, Belgium.
After finalizing his PhD Thesis (2007) on improving anesthetic drug titration using neuro-physiological monitoring, he proceeded an academic career at the University Medical Center Groningen (UMCG) (2010-current), the Netherlands, where he became an assistant professor in anesthesia (2012-current).
He is involved in multiple study-projects related to anesthetic pharmacology, such as: the improvement of pharmacokinetic-dynamic models for anesthetic drugs; using interaction models to predict responsiveness during anesthesia; exploring the use of electroencephalographic derived information to individualize titration of anesthetic drugs.
Dr. Hugo E.M. Vereecke currently combines his academic position with a clinical consultancy at the general hospital AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium (2016-current). He is an experienced lecturer and educator in his domain of expertise. He is co-promotor of several PhD’s and masterthesis. He volunteered in several professional societies and committees: the medical ethical
committee (2014-2016), the sedation committee (2012-2016) and chair of the incident notification commission (2012-2016) at the UMCG, program director, co chair and chair of the scientific programs of several annual meetings of ISAP (San Diego (2015) , Chicago (2017), New Orleans (2022) and the virtual meetings during the COVID pandemic in 2020 and 2021. He is the former treasurer
(2017-2018), secretarial officer (2018-2019), vice-president (2019-2020), president-elect (2020- 2021), and president (2021-2022) of the International
Society of Anaesthetic Pharmacology (ISAP). He was active member of forum 1 of the European Society of Anesthesia and Intensive care (ESAIC) (2018-2023). He is a board member of EuroSIVA(2023-current). His publication list includes peer reviewed research papers, book chapters and
editorials in several national and international scientific journals.
Wintermeeting 2024: Hernan Boveri
Lost in LOC. Titrating to effect. What does it reveal? Dr. Hernán Boveri, Italian Hospital of Buenos Aires, Argentina. Saturday 20 January 9:00-9:30 Currently, propofol is the most widely used intravenous anesthetic drug capable of providing safe general anesthesia. Propofol can be administered using different techniques including target-controlled infusion (TCI).One of the greatest strengths of TCI technology lies in its ability to maintain the pharmacological condition once the predefined clinical effect has been achieved. TCI models were developed based on